Clinical trial

Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer

NCT03849365

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-01-21

PhasePHASE4

Study timeline

Study start (actual)2019-01-21Date precision: day

Registry last updated2021-03-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Low Risk Prostate Cancerunresolved

Interventions

TOOKAD VTPDRUG

Sponsors & collaborators

Steba Biotech S.A.lead sponsor

International Drug Development Institutecollaborator

PrimeVigilance Ltd., UKcollaborator

Mapped research locations

AngersFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03849365 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.